SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-016529
Filing Date
2023-04-05
Accepted
2023-04-05 07:18:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A ny20005373x501_defa14a.htm DEFA14A 8727
2 ny20005373x501_nc1.jpg GRAPHIC 356448
3 ny20005373x501_nc2.jpg GRAPHIC 280543
  Complete submission text file 0001140361-23-016529.txt   887064
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39503 | Film No.: 23801169
SIC: 2836 Biological Products, (No Diagnostic Substances)